A widely used blood pressure medication could help slow the progression of a rare brain disease in children, according to a new study reported by Xinhua.
The research, conducted in Amsterdam, found that the existing drug may reduce the impact of the condition, which affects young patients. The findings were published on Saturday, August 15, 2026, and have drawn attention from multiple outlets, including Sharjah24 and NL Times, which also covered the results.
The study centers on repurposing a drug already approved for hypertension, meaning it could potentially move toward clinical use more quickly than a newly developed treatment. Because the medication is already available and its safety profile is established, researchers may face fewer hurdles in testing it specifically for this brain disease.
The condition in question is described as rare and primarily affects children, though the study’s details on the disease’s exact name and mechanism were not included in the initial reporting. The Amsterdam-based team’s findings suggest that the drug’s effect on blood pressure may also influence the disease process in the brain, though the precise biological link remains unclear from the available information.
According to Xinhua, the study marks a promising step, but it is likely still in early stages. No timeline for further trials or potential regulatory approval was provided in the reporting.
What to watch next: whether follow-up studies confirm the drug’s benefits in larger patient groups and whether regulators consider it for this new use.
